George Jeffrey P.
SEC Form 4 insider trading activity
George Jeffrey P. has filed 2 SEC Form 4 filings (2 transaction rows) across 2 companies, including AMRX, LENZ, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: May 8, 2026.
On the most recent filing, George Jeffrey P. is listed as Director at LENZ Therapeutics, Inc. Inside the rolling window, George Jeffrey P. reported 1 open-market purchase totaling $50K in LENZ and no open-market sales.
Companies traded
Other insiders at AMRX
Insider Buying
$50K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has George Jeffrey P. made?
George Jeffrey P. has filed 2 SEC Form 4 filings (2 transaction rows) across 2 companies, including AMRX, LENZ since 2026.
Which companies does George Jeffrey P. trade?
George Jeffrey P. has filed SEC Form 4 disclosures for 2 companies, including AMRX, LENZ.
When was George Jeffrey P.'s most recent SEC Form 4 filing?
George Jeffrey P.'s most recent SEC Form 4 filing on Tracefour is dated May 8, 2026.
What is George Jeffrey P.'s total buy and sell value in the current window?
Inside the rolling retention window, George Jeffrey P. bought $50K and sold $0 based on SEC Form 4 filings.
What was George Jeffrey P.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 5,592 LENZ shares on 2026-03-27, worth $50K, per SEC Form 4 filings.